GPR35 and neoplasm: Pagano et al. [32] observed that in a mouse colon cancer xenograft, activation of GPR35 (G Protein-Coupled Receptor 35), a target protein for KYNA and 3-HAA, is linked to increased neoangiogenesis, tumor tissue remodeling, and tumor development.